Premananda Indic

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Stephanie Carreiro

> Home > Persons > Premananda Indic

Publications

2023
[c13]
- view
  - electronic edition via handle.net (open access)
  - details & citations
- export record
  dblp key:
  - conf/hicss/ShresthaSTLCI23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/hicss/ShresthaSTLCI23
Sloke Shrestha, Joshua Stapp, Melissa Taylor, Rebecca Leach, Stephanie Carreiro, Premananda Indic:
Towards Device Agnostic Detection of Stress and Craving in Patients with Substance Use Disorder. HICSS 2023: 3156-3163
2020
[c11]
- view
  - electronic edition via handle.net (open access)
  - details & citations
- export record
  dblp key:
  - conf/hicss/KaczorCSCI20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/hicss/KaczorCSCI20
Eric Kaczor, Stephanie Carreiro, Joshua Stapp, Brittany P. Chapman, Premananda Indic:
Objective Measurement of Physician Stress in the Emergency Department Using a Wearable Sensor. HICSS 2020: 1-10
2018
[c8]
- view
- export record
  dblp key:
  - conf/hicss/ChinthaICBC18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/hicss/ChinthaICBC18
Keerthi Kumar Chintha, Premananda Indic, Brittany P. Chapman, Edward W. Boyer, Stephanie Carreiro:
Wearable Biosensors to Evaluate Recurrent Opioid Toxicity After Naloxone Administration: A Hilbert Transform Approach. HICSS 2018: 1-6

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.